South San Francisco, California, 15 September, 2006 - Napo
Pharmaceuticals, Inc., (LSE: NAPL), which focuses on bringing
proprietary products to the global marketplace in collaboration
with local partners, today announces its interim results for the
six months ended 30 June 2006. The Company listed its shares on
the Main Market of the London Stock Exchange in July 2006.
